CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TLC BioSciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TLC BioSciences Corp
Ugland House, Grand Cayman
PO Box 309
TAIPEI, 115  Taiwan Ticker: 79247924
Business Summary
TLC BioSciences Corp is a company specializing in proprietary lipid nanoparticles (LNPs) and lipid carrier drug delivery technologies. It is a biotechnology company dedicated to developing a diverse range of innovative nanomedicine products. The Company and its group primarily focus on developing innovative drugs covering orthopedics, pain management, antifungal infections, metabolic diseases, and immunotherapy by utilizing three proprietary technology platforms, includingBioSeizer controlled-release formulation technology, NanoX precision drug delivery technology, and Genosphere precision gene therapy delivery technology (collectively known as the LipAD technology platform). The Company's key assets include TLC590, TLC599, and TLC166.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025-----

Industries
SIC Code Description
8731 Commercial physical and biological research

General Information
Outstanding Shares: 133,560,687 (As of 6/26/2026)
Stock Exchange: TPO


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 26, 2026